Evidence map›Paper›PMID 29377033›Full record

ArticleCellular & molecular medicine: open access2017

Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis.

Amanda J Fisher, Ellyse Cipolla, Ananya Varre, Hongmei Gu, Elizabeth A Mickler, Ragini Vittal

Open access · diamondAbstract read
In one paragraph

Article in Cellular & molecular medicine: open access, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury.American journal of respiratory cell and molecular biology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amanda J FisherDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Ellyse CipollaDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, USA.
Ananya VarreDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, USA.
Hongmei GuDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Elizabeth A MicklerDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Ragini VittalDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, USA.
Indiana University School of MedicineUniversity of Michigan–Ann Arbor · US

Funding

Role of IL-17 in the Induction of Epithelial to Mesenchymal TransitionR01HL109288 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VITTAL, RAGINI · 2011 to 2015
$1.9M
NHLBI NIH HHS R01 HL109288
6 · The paper itself

Abstract

While our previous studies suggest that limiting bleomycin-induced complement activation suppresses TGF-β signaling, the specific hierarchical interactions between TGF-β and complement in lung fibrosis are unclear. Herein, we investigated the mechanisms underlying TGF-β-induced complement activation in the pathogenesis of lung fibrosis. C57-BL6 mice were given intratracheal instillations of adenoviral vectors overexpressing TGF-β (Ad-TGFβ) or the firefly gene-luciferase (Ad-Luc; control). Two weeks later, mice with fibrotic lungs were instilled RNAi specific to receptors for

Indexed as

C3aRC5aRDAFmiR-200CmiR-21Smad7

Identifiers

PMID29377033
PMCPMC5786162
OpenAlexW2776268606

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.